Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹55Cr
Rev Gr TTM
Revenue Growth TTM
-3.93%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

RCDL
VS
| Quarter | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | -15.3 | 83.7 | 45.8 | -7.1 | 0.4 |
| 226 | 192 | 182 | 362 | 272 | 332 | 273 |
Operating Profit Operating ProfitCr |
| -0.3 | 6.0 | 4.3 | 3.2 | 2.0 | 4.5 | 2.2 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
Interest Expense Interest ExpenseCr | 1 | 1 | 3 | 3 | 3 | 5 | 3 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| -1 | 11 | 6 | 9 | 3 | 13 | 3 |
| 0 | 0 | 2 | 2 | 1 | 3 | 1 |
|
Growth YoY PAT Growth YoY% | | | 241.8 | -18.8 | -48.8 | 13.6 | -5.2 |
| -1.1 | 3.9 | 1.8 | 1.7 | 0.6 | 2.1 | 0.6 |
| 0.0 | 0.0 | 0.0 | 3.4 | 0.7 | 3.0 | 0.7 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -87.6 | -30.3 | 307.0 | 980.8 | 31.7 | 10.7 | 0.2 |
| 110 | 13 | 10 | 37 | 417 | 545 | 604 | 605 |
Operating Profit Operating ProfitCr |
| 2.0 | 9.7 | -1.3 | 6.8 | 2.7 | 3.6 | 3.4 | 3.5 |
Other Income Other IncomeCr | 0 | 1 | 1 | 1 | 0 | 0 | 2 | 2 |
Interest Expense Interest ExpenseCr | 1 | 2 | 2 | 2 | 2 | 5 | 8 | 8 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| 1 | -1 | -3 | 0 | 9 | 14 | 14 | 16 |
| 0 | 0 | -1 | 0 | 3 | 4 | 5 | 4 |
|
| | -369.9 | -85.7 | 129.0 | 962.4 | 76.5 | -7.9 | -1.0 |
| 0.3 | -6.9 | -18.5 | 1.3 | 1.3 | 1.7 | 1.4 | 1.4 |
| 418.5 | -82.3 | -152.9 | 6.3 | 30.1 | 5.2 | 3.8 | 3.7 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 0 | 0 | 0 | 0 | 2 | 24 | 24 |
| 4 | 3 | 1 | 2 | 22 | 50 | 59 |
Current Liabilities Current LiabilitiesCr | 4 | 14 | 15 | 29 | 48 | 110 | 70 |
Non Current Liabilities Non Current LiabilitiesCr | 19 | 10 | 9 | 6 | 6 | 4 | 2 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 3 | 3 | 2 | 16 | 57 | 164 | 133 |
Non Current Assets Non Current AssetsCr | 24 | 23 | 23 | 22 | 21 | 23 | 23 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 2 | 2 | 3 | 7 | -40 | -34 | 11 |
Investing Cash Flow Investing Cash FlowCr | -23 | -1 | -3 | 0 | -1 | -4 | 1 |
Financing Cash Flow Financing Cash FlowCr | 21 | -1 | 0 | -7 | 41 | 38 | -12 |
|
Free Cash Flow Free Cash FlowCr | -20 | 2 | 3 | 7 | -41 | -37 | 10 |
| 588.9 | -230.5 | -148.1 | 1,406.4 | -724.8 | -352.1 | 122.5 |
CFO To EBITDA CFO To EBITDA% | 92.1 | 165.1 | -2,128.2 | 272.7 | -348.9 | -170.6 | 52.4 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 0 | 83 | 41 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.5 | 4.5 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 0.5 |
| 7.9 | 13.8 | -161.2 | 6.5 | 3.8 | 6.4 | 4.0 |
Profitability Ratios Profitability Ratios |
| 5.5 | 10.6 | 0.9 | 7.2 | 5.5 | 5.5 | 4.7 |
| 2.0 | 9.7 | -1.3 | 6.8 | 2.7 | 3.6 | 3.4 |
| 0.3 | -6.9 | -18.5 | 1.3 | 1.3 | 1.7 | 1.4 |
| 7.3 | 4.5 | -1.0 | 12.7 | 15.0 | 15.5 | 17.0 |
| 8.3 | -29.4 | -120.3 | 25.9 | 23.4 | 13.2 | 10.8 |
| 1.3 | -3.7 | -7.0 | 1.4 | 7.1 | 5.2 | 5.8 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Rajgor Castor Derivatives Limited (**RCDL**) is an Indian manufacturer and trader specializing in castor oil and its derivatives. Since a strategic management change in **January 2022**, the company has transitioned from a pure trading and leasing model to an integrated manufacturing entity. Following its successful listing on the **NSE Emerge** platform in **October 2023**, RCDL has positioned itself as a high-growth player in the global agro-chemical and industrial feedstock markets.
### Integrated Manufacturing and Strategic Sourcing Ecosystem
RCDL operates a state-of-the-art manufacturing facility in **Harij, Gujarat**, with a robust production capacity of **450 MT per day**. The facility’s location is a core competitive advantage, providing proximity to both supply and distribution hubs.
* **Sourcing Advantage:** Gujarat accounts for approximately **80%** of India’s castor seed production. RCDL procures raw materials directly from local farmers and **APMCs** (Agricultural Produce Market Committees), ensuring supply chain security.
* **Logistical Efficiency:** The plant is strategically located near the **Mundra Port**, facilitating cost-effective international distribution and supporting the company's aggressive export expansion.
* **Operational Maintenance:** The company maintains high industrial standards, though it undergoes scheduled annual maintenance (e.g., a month-long shutdown in **August-September**) which can cause temporary production fluctuations.
### Specialized Product Portfolio and Industrial Utility
The company focuses on high-purity oil and nutrient-dense derivatives catering to pharmaceutical, cosmetic, and agricultural sectors.
| Product Category | Key Specifications | Primary Applications |
| :--- | :--- | :--- |
| **Refined Castor Oil (F.S.G.)** | **First Special Grade**; meets **British Standard Specifications**. | **Pharmaceuticals** (tablet coatings), **Cosmetics**, **Lubricants**, and **Biodiesel**. |
| **Castor De-Oiled Cake (D.O.C.)** | Rich in **Nitrogen, Phosphorus, and Potassium (NPK)**. | **Organic Fertilizer** for soil health and moisture retention. |
| **High Protein Castor Meal (HPCM)** | **>50% Protein content**; balanced amino acid profile. | **Livestock Feed Supplement** for poultry, cattle, and aquaculture. |
The refining process for **F.S.G. Oil** is specifically designed to remove allergenic proteins and toxins like **ricin**, making it a critical precursor for medicinal and high-end industrial applications.
### Financial Performance and Capital Structure
RCDL has demonstrated significant revenue scaling, crossing the **₹625 Crore** mark in **FY25**. The **October 2023 IPO** (Fresh issue of **8,895,000 shares** at **₹50** per share) significantly strengthened the balance sheet.
**Key Financial Metrics:**
| Metric (₹ Crore) | FY23 (Audited) | FY24 (Audited) | FY25 (Audited) |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | 428.78 | 564.84 | **625.40** |
| **Net Profit (PAT)** | 5.54 | 9.78 | **9.01** |
| **Net Worth** | 23.66 | 74.22 | **83.00** |
| **Total Debt** | 44.51 | 47.44 | **53.63** |
**Solvency and Liquidity:**
* **Gearing Ratio:** Improved drastically from **1.87x** (FY23) to **0.51x** (FY25).
* **Current Ratio:** Stands at a healthy **1.92 times** (FY25).
* **Credit Rating:** Reaffirmed at **IVR BBB/ Stable** (Long Term) and **IVR A3+** (Short Term) by Infomerics in February 2026.
* **Operating Cycle:** Elongated to **35 days** in FY24 (from **13 days** in FY23) as a strategic move to boost sales volumes.
### Strategic Growth Pillars and Global Expansion
The company is transitioning from a domestic manufacturer to a global supplier, leveraging the "China Plus One" sentiment in global supply chains.
* **Export Surge:** Export turnover grew by over **430%** in a single year, rising from **₹3.97 Crore** in FY24 to **₹21.06 Crore** in FY25, targeting markets in the **USA, Singapore, and Thailand**.
* **Capital Headroom:** Shareholders approved an increase in authorized capital from **₹24 Crore** to **₹56.50 Crore** (effective April 2026) and raised the **FII/FPI limit to 100%** to invite global institutional investment.
* **Leadership Stability:** **Mr. Brijeshkumar Vasantlal Rajgor** has been re-appointed as Managing Director through **August 2030**, ensuring long-term strategic continuity.
* **Digitalization:** Implementation of **smart manufacturing** systems to improve traceability and quality control for pharmaceutical-grade clients.
### Related Party Ecosystem and Synergies
RCDL operates within a broader group of "sister concern" companies that optimize the supply chain and mitigate demand risks through arm's-length transactions.
* **Key Entities:** Rajgor Agro Limited, Rajgor Proteins Limited, Exaoil Refinery Limited, and Koovey Oleo Science Private Limited.
* **Transaction Thresholds:** For **FY 2025-26**, the company sought approval for material related party transactions (RPTs) up to **₹100 Crore** each for Rajgor Proteins and Rajgor Agro, reflecting the deep integration of the group's manufacturing and trading activities.
### Risk Profile and Mitigation Strategies
Despite a stable outlook, RCDL faces several inherent industry risks:
* **Commodity and Raw Material Risk:** India’s castor seed production is forecasted to drop to **15.6 lakh tonnes** in FY25 (from **20.54 lakh tonnes**). RCDL mitigates this through its proximity to Gujarat's primary growing regions and active **hedging** of product prices.
* **Geographical Concentration:** Approximately **94%** of FY25 revenue is derived from **Gujarat and Maharashtra**. Expansion into international markets is the primary strategy to de-risk this concentration.
* **Macroeconomic and Geopolitical Factors:** Tensions in the **Red Sea** and the **Russia-Ukraine** conflict have historically impacted freight costs and lead times. The company manages this through cautious inventory planning and forex hedging.
* **Substitution Risk:** Castor-based derivatives compete with **crude-based** alternatives. RCDL counters this by emphasizing the **ESG and sustainability** benefits of bio-based products to global buyers.
* **Regulatory Compliance:** The company monitors stringent international quality standards for its pharmaceutical exports and has addressed minor technical non-compliances (such as a brief delay in appointing a Company Secretary) to align with **SEBI LODR** regulations.